Soy Milk Consumption and Blood Pressure Among Type 2 Diabetic Patients With Nephropathy

Journal of Renal Nutrition

Volumn 23, Issue 4, 2013, Pages

  Miraghajani, Maryam Sadat ^a,b   Najafabadi, Mojgan Mortazavi ^c   Surkan, Pamela J ^d   Esmaillzadeh, Ahmad ^a,b   Mirlohi, Maryam ^a,b   Azadbakht, Leila ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE MAX;

EID: 84879420652     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2013.01.017     Document Type: Article

References (40)

1. Abe H. Recent progress in understanding the molecular pathogenesis of diabetic nephropathy. Rinsho Byori 2011, 59:179-186.
2. Miyata T. Novel mechanisms and therapeutic options in diabetic nephropathy. Pol Arch Med Wewn 2009, 119:261-264.
3. Almeida J.C., Zelmanovitz T., Vaz J.S., et al. Sources of protein and polyunsaturated fatty acids of the diet and microalbuminuria in type 2 diabetes mellitus. J Am Coll Nutr 2008, 27:528-537.
4. Shidfar F., Ehramphosh E., Heydari I., Haghighi L., Hosseini S., Shidfar S. Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women. Int J Food Sci Nutr 2009, 60:195-205.
5. Pipe E.A., Gobert C.P., Capes S.E., Darlington G.A., Lampe J.W., Duncan A.M. Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J Nutr 2009, 139:1700-1706.
6. Mezei O., Banz W.J., Steger R.W., Peluso M.R., Winters T.A., Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 2003, 133:1238-1243.
7. Teixeira S.R., Tappenden K.A., Carson L., et al. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 2004, 134:1874-1880.
8. Azadbakht L., Atabak S., Esmaillzadeh A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care 2008, 31:648-654.
9. Azadbakht L., Esmaillzadeh A. Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: a crossover, randomized clinical trial. J Ren Nutr 2009, 19:479-486.
10. Azadbakht L., Shakerhosseini R., Atabak S., Jamshidian M., Mehrabi Y., Esmaill-Zadeh A. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy. Eur J Clin Nutr 2003, 57:1292-1294.
11. Choi Y.E., Ahn S.K., Lee W.T., et al. Soybeans ameliolate diabetic nephropathy in rats. Evid Based Complement Alternat Med 2010, 7:433-440.
12. Miraghajani M.S., Esmaillzadeh A., Najafabadi M.M., Mirlohi M., Azadbakht L. Soy milk consumption, inflammation, coagulation, and oxidative stress among type 2 diabetic patients with nephropathy. Diabetes Care 2012, 35:1981-1985.
13. Reinwald S., Akabas S.R., Weaver C.M. Whole versus the piecemeal approach to evaluating soy. J Nutr 2010, 140:2335S-2343S.
14. Torres y Torres N., Palacios-González B., Noriega-López L., Tovar-Palacio A.R. Glycemic, insulinemic index, glycemic load of soy beverage with low and high content of carbohydrates. Rev Invest Clin 2006, 58:487-497.
15. Mateos-Aparicio I., Redondo Cuenca A., Villanueva-Suárez M.J., Zapata-Revilla M.A. Soybean, a promising health source. Nutr Hosp 2008, 23:305-312.
16. Nutritional care in chronic renal failure. Applications in Medical Nutrition Therapy 1996, 276. Prentice Hall, Upper Saddle River, NJ. 2nd ed. F.J. Zeman, D.M. Ney (Eds.).
17. Dorosti A.R., Tabatabaei M. Food Composition Table 2007, Nutrition's World, Tehran, Iran, [in Persian]. 1386. 1st ed.
18. Franke A.A., Ashburn L.A., Kakazu K., Suzuki S., Wilkens L.R., Halm B.M. Apparent bioavailability of isoflavones after intake of liquid and solid soya foods. Br J Nutr 2009, 102:1203-1210.
19. Meyers B.D., Bennett P.H. Clinical evolution of renal disease in insulin dependent and non insulin dependent diabetes mellitus. Principle and Practice of Nephrology 1991, 464. BC Decker, Philadelphia, PA. H.R. Jacobson, G.E. Striker, S. Klahr (Eds.).
20. Institute of Medicine, Food and Nutrition Board Dietary Reference Intake for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids 2002, National Academies Press, Washington, DC.
21. Nozawa S., Hakoda A., Sakaida K., Suzuki T., Yasui A. Method performance study of the determination of total nitrogen in soy sauce by the Kjeldahl method. Anal Sci 2005, 21:1129-1132.
22. Díaz-Castelazo C., Rico-Gray V., Ortega F., Angeles G. Morphological and secretory characterization of extrafloral nectaries in plants of coastal Veracruz, Mexico. Ann Bot 2005, 96:1175-1189.
23. Kleyn D.H., Lynch J.M., Barbano D.M., Bloom M.J., Mitchell M.W. Determination of fat in raw and processed milks by the Gerber method: collaborative study. J AOAC Int 2001, 84:1499-1508.
24. Faerk J., Skafte L., Petersen S., Peitersen B., Michaelsen K.F. Macronutrients in milk from mothers delivering preterm. Adv Exp Med Biol 2001, 501:409-413.
25. Chang J.H., Kim M.S., Kim T.W., Lee S.S. Effects of soybean supplementation on blood glucose, plasma lipid levels, and erythrocyte antioxidant enzyme activity in type 2 diabetes mellitus patients. Nutr Res Pract 2008, 2:152-157.
26. Kowluru R.A., Zhong Q., Kanwar M. Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes. Exp Eye Res 2010, 90:617-623.
27. Van Buren P.N., Toto R. Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis 2011, 18:28-41.
28. Taku K., Lin N., Cai D., et al. Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebo-controlled trials. J Hypertens 2010, 28:1971-1982.
29. Nagarajan S., Burris R.L., Stewart B.W., Wilkerson J.E., Badger T.M. Dietary soy protein isolate ameliorates atherosclerotic lesions in apolipoprotein E-deficient mice potentially by inhibiting monocyte chemoattractant protein-1 expression. J Nutr 2008, 138:332-337.
30. Tachibana N., Iwaoka Y., Hirotsuka M., Horio F., Kohno M. Beta-conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats. Biosci Biotechnol Biochem 2010, 74:1250-1255.
31. Si H., Liu D. Genistein, a soy phytoestrogen, upregulates the expression of human endothelial nitric oxide synthase and lowers blood pressure in spontaneously hypertensive rats. J Nutr 2008, 138:297-304.
32. De Leo F., Panarese S., Gallerani R., Ceci L.R. Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food. Curr Pharm Des 2009, 15:3622-3643.
33. Rau De Almeida Callou K., Sadigov S., Lajolo F.M., Genovese M.I. Isoflavones and antioxidant capacity of commercial soy-based beverages: effect of storage. J Agric Food Chem 2010, 58:4284-4291.
34. Kano M., Takayanagi T., Harada K., Sawada S., Ishikawa F. Bioavailability of isoflavones after ingestion of soy beverages in healthy adults. J Nutr 2006, 136:2291-2296.
35. Rüfer C.E., Kulling S.E. Antioxidant activity of isoflavones and their major metabolites using different invitro assays. J Agric Food Chem 2006, 54:2926-2931.
36. Ozasa K., Nakao M., Watanabe Y., et al. Association of serum phytoestrogen concentration and dietary habits in a sample set of the JACC Study. J Epidemiol 2005, 15:S196-S202.
37. Vergne S., Sauvant P., Lamothe V., et al. Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br J Nutr 2009, 102:1642-1653.
38. Chi D., Nakano M., Yamamoto K. Milk and milk products consumption in relationship to serum lipid levels: a community-based study of middle-aged and older population in Japan. Cent Eur J Public Health 2004, 12:84-87.
39. Melnik B.C. Milk-the promoter of chronic Western diseases. Med Hypotheses 2009, 72:631-639.
40. Schrezenmeir J., Jagla A. Milk and diabetes. J Am Coll Nutr 2000, 19:176S-190S.